Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin Tablets
NCT07023172
·
clinicaltrials.gov ↗
RECRUITING
Status
3000
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School